The role of serum pepsinogen level and Helicobacter pylori infection in esophageal carcinoma remains controversial. It may be a risk or protective factor, or without association with esophageal carcinoma. We prospectively examined associations between serum pepsinogen status, H pylori infection and the risk of esophageal squamous cell carcinoma in the Chinese population.
Methods
In the present study, 1501 subjects from a community-based general population of Northern China were included. The incidence of esophageal carcinoma among the subjects was registered during a 15-year follow-up period by annual home visit, and the risks of low serum pepsinogen level and H pylori infection in the development of ESCC were evaluated using logistic regression.
Results
The total accumulated incidence of ESCC in the cohort was 666/100,000 during the 15-year follow-up. Notably, all the cases were verified to be ESCC. Logistic regression analysis showed that age ≥60 (OR = 9.67; 95% CI, 2.797–33.423) was the only risk factor for esophageal squamous cell carcinoma in the population. There was no significant association between sex, H pylori infection, pepsinogen level (PG I ≤70 ng/ml alone, PG I/II ratio ≤3 alone, or PG I ≤70 ng/ml and PG I/II ratio ≤3) and esophageal squamous cell carcinoma.
Conclusions
In this prospective study, neither H pylori infection nor abnormal pepsinogen status had a predictive role for the development of esophageal squamous cell carcinoma in the rural population of China.
CookM.B., ChowW.H., DevesaS.S.: Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005.Br J Cancer, 101: 855–859, 2009.
2.
BosettiC., LeviF., FerlayJ., GaravelloW., LucchiniF., BertuccioP., NegriE., La VecchiaC.: Trends in oesophageal cancer incidence and mortality in Europe.Int J Cancer, 122: 1118–1129, 2008.
3.
HeY.T., HouJ., ChenZ.F., QiaoC.Y., SongG.H., MengF.S., JinH.X., ChenC.: Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China.Eur J Cancer Prev, 17: 71–76, 2008.
4.
LuC.L., LangH.C., LuoJ.C., LiuC.C., LinH.C., ChangF.Y., LeeS.D.: Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan.Cancer Causes Control, 21: 269–274, 2010.
RichterJ.E., FalkG.W., VaeziM.F.: Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad.Am J Gastroenterol, 93: 1800–1802, 1998.
8.
HoubenG.M., StockbruggerR.W.: Bacteria in the aetiopathogenesis of gastric cancer: a review.Scand J Gastroenterol Suppl, 212: 13–18, 1995.
9.
VicariJ.J., PeekR.M., FalkG.W., GoldblumJ.R., EasleyK.A., SchnellJ., Perez-PerezG.I., HalterS.A., RiceT.W., BlaserM.J., RichterJ.E.: The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.Gastroenterology, 115: 50–57, 1998.
10.
ChowW.H., BlaserM.J., BlotW.J., GammonM.D., VaughanT.L., RischH.A., Perez-PerezG.I., SchoenbergJ.B., StanfordJ.L., RotterdamH., WestA.B., FraumeniJ.F.Jr.: An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.Cancer Res, 58: 588–590, 1998.
11.
WestonA.P., BadrA.S., TopalovskiM., CherianR., DixonA., HassaneinR.S.: Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.Am J Gastroenterol, 95: 387–394, 2000.
12.
AdamuM.A., WeckM.N., RothenbacherD., BrennerH.: Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow-up of a population-based cohort study.Int J Cancer, 128: 1652–1658, 2011.
13.
InoueM., KobayashiS., MatsuuraA., HamajimaN., TajimaK., TominagaS.: Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis.Cancer Epidemiol Biomarkers Prev, 7: 261–263, 1998.
14.
IijimaK., KoikeT., AbeY., InomataY., SekineH., ImataniA., NakayaN., OharaS., ShimosegawaT.: Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan.Am J Gastroenterol, 102: 1603–1609, 2007.
YeW., HeldM., LagergrenJ., EngstrandL., BlotW.J., McLanghlinJ.K., NyrénO.: Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.J Natl Cancer Inst, 96: 388–396, 2004.
17.
VriesA.C., CapelleL.G., LoomanC.W., BlankensteinM., GriekenN.C., CasparieM.K., MeijerG.A., KuipersE.J.: Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes.Int J Cancer, 124: 2135–2138, 2009.
18.
RenJ.S., KamangarF., QiaoY.L., TaylorP.R., LiangH., DawseyS.M., LiuB., FanJ.H., AbnetC.C.: Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.Gut, 58: 636–642, 2009.
19.
VeneritoM., KohrsS., WexT., AdolfD., KuesterD., SchubertD., PeitzU., MönkemüllerK., MalfertheinerP.: Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study.Eur J Gastroenterol Hepatol, 23: 859–864, 2011.
20.
AokiK., KihaileP.E., WenyuanZ., XianghangZ., CastroM., DislaM., NyamboT.B., MisumiJ.: Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic.Ann Epidemiol, 15: 598–606, 2005.
21.
WatanabeY., KurataJ.H., MizunoS., MukaiM., InokuchiH., MikiK., OzasaK., KawaiK.: Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.Dig Dis Sci, 42: 1383–1387, 1997.
22.
ZhangX., XueL., XingL., WangJ., CuiJ., MiJ., XingX., WangJ., DuZ., MisumiJ., TianQ., WangL.: Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow-up result in a rural Chinese community.Int J Cancer, 130: 1614–1619, 2012.
23.
WatabeH., MitsushimaT., YamajiY., OkamotoM., WadaR., KokuboT., DoiH., YoshidaH., KawabeT., OmataM.: Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.Gut, 54: 764–768, 2005.
24.
VannellaL., LahnerE., OsbornJ., BordiC., MiglioneM., DelleFave, AnnibaleB.: Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.Aliment Pharmacol Ther, 31: 1042–1050, 2010.
25.
MizunoS., MikiI., IshidaT., YoshidaM., OnoyamaM., AzumaT., HabuY., InokuchiH., OzasaK., MikiK., WatanabeY.: Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.Dig Dis Sci, 55: 3132–3137, 2010.
26.
YokoyamaA., OmoriT., YokoyamaT., KawakuboH., MoriS., MatsuiT., MaruyamaK.: Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma.Alcohol Clin Exp Res, 33: 898–905, 2009.
27.
CookM.B., DawseyS.M., DiawL., BlaserM.J., Perez-PerezG.I., AbnetC.C., TaylorP.R., AlbanesD., VirtamoJ., KamangarF.: Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.Cancer Epidemiol Biomarkers Prev, 19: 1966–1975, 2010.
28.
SaievaC., RubioC.A., NesiG., ZiniE., FilomenaA.: Classification of Gastritis in first-degree relatives of patients with gastric cancer in a high cancer-risk area in Italy.Anticancer Res, 32: 1711–1716, 2012.
29.
CraddockV.M.: Aetiology of oesophageal cancer: some operative factors.Eur J Cancer Prev, 1: 89–103, 1992.
30.
HoubenG.M., StockbruggerR.W.: Bacteria in the aetiopathogenesis of gastric cancer: a review.Scand J Gastroenterol Suppl, 212: 13–18, 1995.
31.
KhoshbatenM., ZadimaniA., BonyadiM.R., MohammadzadehM., GachkarL., PourhoseingholiM.A.: Helicobacter pylori infection reduces the risk of esophageal squamous cell carcinoma: a case-control study in Iran.Asian Pac J Cancer Prev, 12: 149–151, 2011.
32.
RokkasT., PistiolasD., SechopoulosP., RobotisI., MargantinisG.: Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis.Clin Gastroenterol Hepatol, 5: 1413–1417, 2007.
